He Y - Search Results

1

Plasma EGFR mutation ctDNA dynamics in patients with advanced EGFR-mutated NSCLC treated with Icotinib: phase 2 multicenter trial result.

Hong Y, Zhuang W, Lai J, Xu H, He Y, Lin J, Shi Q, Chen S, Huang Z, Chen S, Lu D, Lin G, Huang Y. Hong Y, et al. Among authors: he y. Sci Rep. 2024 Oct 4;14(1):23115. doi: 10.1038/s41598-024-73749-2. Sci Rep. 2024. PMID: 39367090 Free PMC article. Clinical Trial.

2

Different Types of ROS1 Fusion Partners Yield Comparable Efficacy to Crizotinib.

He Y, Sheng W, Hu W, Lin J, Liu J, Yu B, Mao X, Zhang L, Huang J, Wang G. He Y, et al. Oncol Res. 2019 Aug 8;27(8):901-910. doi: 10.3727/096504019X15509372008132. Epub 2019 Mar 25. Oncol Res. 2019. PMID: 30940295 Free PMC article.

3

Preliminary study on the clinical significance of kinesin Kif18a in nonsmall cell lung cancer: An analysis of 100 cases.

Guo W, Zeng H, Zheng J, He Y, Zhuang X, Cai J, Huang H, Huang H, Xu M. Guo W, et al. Among authors: he y. Medicine (Baltimore). 2020 Jan;99(4):e19011. doi: 10.1097/MD.0000000000019011. Medicine (Baltimore). 2020. PMID: 31977917 Free PMC article.

4

Correlated low IGF2BP1 and FOXM1 expression predicts a good prognosis in lung adenocarcinoma.

Huang H, Wang D, Guo W, Zhuang X, He Y. Huang H, et al. Among authors: he y. Pathol Res Pract. 2019 Jul;215(7):152433. doi: 10.1016/j.prp.2019.152433. Epub 2019 May 4. Pathol Res Pract. 2019. PMID: 31085008

5

The effect of afatinib in a pretreated patient with invasive mucinous adenocarcinoma of the lung harboring HER2 YVMA insertion: a case report.

He Y, Huang H, Xu M, Fu Z, Zhang X, Chen X, Guo W. He Y, et al. Transl Cancer Res. 2022 Jun;11(6):1819-1823. doi: 10.21037/tcr-22-1457. Transl Cancer Res. 2022. PMID: 35836522 Free PMC article.

6

Concordance of Genomic Profiles in Matched Tissue and Plasma Samples From Chinese Patients With Lung Cancer.

He Y, Guo W, Xu M, Huang J, Zhang X, Su H, Hong D, Liu Q. He Y, et al. Clin Med Insights Oncol. 2022 Oct 20;16:11795549221116834. doi: 10.1177/11795549221116834. eCollection 2022. Clin Med Insights Oncol. 2022. PMID: 36310733 Free PMC article.

7

Case report: Favorable efficacy of combined afatinib and anlotinib treatment in a lung adenocarcinoma patient harboring uncommon EGFR L858M/L861R mutations.

He Y, Wu Y, He R, Xu M, Chen H, Meng Y, Zheng L, Wang L. He Y, et al. Among authors: he r. Front Pharmacol. 2024 Nov 29;15:1437086. doi: 10.3389/fphar.2024.1437086. eCollection 2024. Front Pharmacol. 2024. PMID: 39679364 Free PMC article.

8

Apatinib-based targeted therapy against pulmonary sarcomatoid carcinoma: a case report and literature review.

Li X, He Y, Zhu J, Pang H, Lin Y, Zheng J. Li X, et al. Among authors: he y. Oncotarget. 2018 Sep 14;9(72):33734-33738. doi: 10.18632/oncotarget.25989. eCollection 2018 Sep 14. Oncotarget. 2018. PMID: 30263099 Free PMC article.

9

The diagnostic value of D-dimer with simplified Geneva score (SGS) pre-test in the diagnosis of pulmonary embolism (PE).

Fu Z, Zhuang X, He Y, Huang H, Guo W. Fu Z, et al. Among authors: he y. J Cardiothorac Surg. 2020 Jul 20;15(1):176. doi: 10.1186/s13019-020-01222-y. J Cardiothorac Surg. 2020. PMID: 32690039 Free PMC article.

10

N-Phenylphenothiazine-based Hyper-cross-linked Polymers for Recyclable, Heterogeneous Photocatalysis of Organic Transformations: A Strategy to Access 6-Difluoromethyl-phenanthridines.

Song S, Wang W, He Y, Cheng X, Chen Z, Zhou J, Li J. Song S, et al. Among authors: he y. Org Lett. 2025 Jan 23. doi: 10.1021/acs.orglett.4c04585. Online ahead of print. Org Lett. 2025. PMID: 39848622

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,940 results

Search Page

Filters